Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.19.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (2,342,677) $ (2,763,492)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation 839 839
Stock based compensation 1,145,000 827,300
Amortization of prepaid insurance 25,768 20,959
Amortization of debt discount 18,662 580,663
Amortization of intangible assets 3,158 9,476
Unrealized gain on marketable securities (25,000) 0
Change in operating assets and liabilities:    
Increase in accounts receivable (13,000) 0
Increase in prepaid expenses 0 (6,742)
Increase in inventory (68,676) 987
Increase in due to First Insurance Funding (23,280) (22,807)
Increase in accounts payable and accrued expenses 545,705 189,455
Decrease in security deposits 4,952 0
Net cash used in operating activities (728,549) (1,163,362)
CASH FLOW FROM INVESTING ACTIVITIES: 0 0
CASH FLOW FROM FINANCING ACTIVITIES:    
Repayment of convertible notes 0 (168,888)
Common stock issued under registration statement on Form S-3 1,592,812 0
Repayment of shareholders loans (7,500) 0
Net cash provided by (used in) financing activities 1,585,312 (168,888)
Net increase (decrease) in cash and cash equivalents 856,763 (1,332,250)
Cash and cash equivalents at beginning of period 1,805,627 2,057,843
Cash and cash equivalents at end of period 2,662,390 725,593
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Interest 0 164,890
Income taxes - net of tax refund 0 0
NON-CASH INVESTING AND FINANCING ACTIVITIES    
Common stock issued against CS subscription 400,000 0
Common stock issued against common stock to be issued 0 15,000
Common stock issued against conversion of debt and interest $ 0 $ 403,482